Yantao Chen* and
James Gibson
AstraZeneca Innovative Medicines Cardiovascular and Metabolic Diseases, S-431 83 Mölndal, Sweden. E-mail: yantao.chen@astrazeneca.com; yantaochen.se@gmail.com; Fax: +46-31-776-3710; Tel: +46-31-706-5577 Tel: +46-72-589-9827
First published on 8th December 2014
Sulfonimidamides were prepared in a one-pot transformation from sulfonamides, through nucleophilic substitution of sulfonimidoyl chlorides formed in situ with different amines. This methodology represents a convenient, safe, and easily accessible synthetic route to sulfonimidamides.
Recently SIAs have been proposed as bioisosteres of SAs and carboxylic acids.8 The replacement of SAs with SIAs can be a useful approach for the optimisation of lead compounds in drug discovery. However this replacement has been little-used, presumably due to the limitation of the synthesis of sulfonimidoyl chlorides (SICs) – the key intermediates to SIAs.
The first reported approaches to SICs were from Levchenko (Scheme 1).9
The oxidative route (approach 1) is based on the reaction of sulfinyl chlorides with N-halogen compounds.10 Contemporary routes employ oxidative chlorinating reagents such as chlorine, N-chlorobenzotriazole,11 tert-butyl hypochlorite,12 anhydrous chloramine-T,13 and N-chlorosuccinimide2,8b,14a to synthesise SIAs from sulfinamide substrates. However, this approach has limitations as the accessibility and ease of handling of sulfinyl chlorides or sulfinamides, is usually poor compared to the corresponding sulfur(VI) compounds. Oxidative chlorinating reagents, such as tert-butyl hypochlorite, are high-energy or unstable compounds that require special care.14
Levchenko also used phosphorus pentachloride (PCl5) as direct chlorinating reagent.15 In 1993, Roy synthesised sulfonimidates from SICs, which were directly synthesised from trimethylsilyl (TMS) group substituted SAs and triphenyldichlorophosphorane (Ph3PCl2) – a replacement of PCl5.14b
To our knowledge, a one-pot methodology for the synthesis of SIAs from SAs has not been reported. We herein describe a one-pot procedure for the synthesis of SIAs: (1) synthesis of fresh Ph3PCl2; (2) in situ synthesis of SICs from SAs; (3) nucleophilic substitution with amines or anilines to afford SIAs; and (4) acidic workup on the tert-butyl dimethylsilyl group (TBS) protected intermediates to afford the products in moderate to excellent yields (Scheme 2).
Because primary SAs will react with in situ formed SICs, sulfonamide-N protection is necessary. In this work we changed TMS, which was used by Roy, into the TBS group as it proved to be more stable (relevant experiments available in the ESI†). Additionally, the TBS protected SIAs can be isolated by column chromatography. Fig. 1 shows the structure of substrates 1–3 that were used in this work and the relevant intermediates – SICs 1a–3a, and 2b, which was only used for the stability study.
Reaction conditions were screened using 0.1 mmol of substrate 3 (Table 1). The relevant SIC 3a was reported by Tillett through the reaction of 4-methylbenzene-1-sulfonyl chloride and N,4-dichlorobenzamide – an intermediate that was synthesised from 4-chlorobenzamide.16 In our work, it was directly synthesised from 3. In practice, few drops of the reaction mixture of SIC 3a were mixed with an excess of ethylamine to convert 3a into N-ethyl sulfonimidamide 3b, which could be detected by LCMS.
Entrya | Solvent | Time (h) | Temp (°C) | Conversionb to 3b% |
---|---|---|---|---|
a 1.02 eq. Ph3PCl2, 1.5 eq. base (DIPEA or TEA) were used.b As determined by LCMS.c Pyridine was used as base.d 4-Methylpyridine was used as base.e 2-Methoxypyridine was used as base.f Acetonitrile (30% vol) was used as co-solvent.g THF (30% vol) was used as co-solvent. | ||||
1 | CHCl3 | 24 | rt | 57 |
2c | CHCl3 | 24 | rt | 15 |
3 | CHCl3 | 4 | 35 | 90 |
4 | CHCl3 | 6 | 35 | 95 |
5 | CHCl3 | 6 | 45 | 61 |
6d | CHCl3 | 4 | 35 | 16 |
7e | CHCl3 | 4 | 35 | 10 |
8c | CHCl3 | 4 | 35 | 25 |
9f | CHCl3 | 4 | 35 | 21 |
10g | CHCl3 | 4 | 35 | 45 |
11 | THF | 4 | 35 | 10 |
For substrate 3, entry 4 showed the best results. For substrates 1 and 2, we kept the same conditions as in entry 4, but optimised temperature and reaction time. The optimal conditions for these three substrates were shown in the tables below. When TBS protecting group was applied, some of the products were deprotected to give final products (Tables 2–4).
a Reactions were usually conducted on a 1.0 mmol scale unless specifically stated. Conditions: (i) 1 (1.0 mmol), Ph3PCl2 (1.1 mmol), triethylamine (TEA, 1.5 mmol), CHCl3 (3.0 mL), 0 °C, 20 min; (ii) amines/anilines (3.0 mmol), 0 °C for 30 min, and then rt for 30 min to 2 days; (iii) aqueous acid (HCl, HCOOH, or HOAc) or HCl/dioxane, 20–90 min. |
---|
![]() |
a Conditions: (i) 1 (1.0 mmol), Ph3PCl2 (1.1 mmol), triethylamine (TEA, 1.5 mmol), CHCl3 (3.0 mL), 35 °C, 6 h; (ii) amines/anilines (3.0 mmol), 30 min, room temperature. |
---|
![]() |
Migration of a proton from one nitrogen atom to another in a SIA structure leads to tautomerisation. A recent report on tautomerism of SIAs by Arvidsson was based on theoretical calculations.2 In our work 1H NMR (DMSO-d6 as solvent for all compounds) was used to determine the stable forms of tautomers. Compounds 4a, 5a, and 5b are TBS-protected products. Therefore, protons on N can only sit on the sp3 N atoms. The chemical shifts of these protons (S–NH2) are >6.10 ppm. Interestingly, the chemical shifts of the protons on the sp2 N atoms (SNH) in compounds 4d, 4e are generally below 4.5 ppm. This chemical shift difference of protons on sp3 N and sp2 N atoms was applied to facilitate the structure determination. For instance, two different NH peaks were found in compounds 4c, 4h, 4i, and 5e. This means that there is no tautomerism (in NMR solvent) after TBS deprotection. On the other hand, only one relevant peak is found in compounds 4f, 4g, 4j, 4k, and 5d. One can conclude that tautomerism happens on those compounds to give the more stable forms (in NMR solvent). The similarity of 4-Br-phenyl and 4-Cl-phenyl groups in 6f makes a clear structure determination difficult. The observed NH chemical shifts in compounds 6e, 6f are very similar, and they are different from the NH chemical shift in 6g. We speculate that a rapid proton exchange exists in 6e and 6f, but not in 6g. From an electronegativity perspective, the structure of 6f is empirically proposed as shown in Table 4. In general, all compounds in Table 4 keep the S
N double bonds connecting to the 4-Cl-phenyl groups without tautomerism.
Enantiomerically pure SIA (S)-4j and its analogues were used in the intermolecular nitrene C–H insertion.5f The corresponding SICs were obtained by action of anhydrous chloramine-T with sulfinyl chlorides, which were be prepared by treatment of the corresponding sulfinate salts with thionyl chloride. Then they reacted with (R)-(−)-α-methylbenzylamine, followed by diastereoisomer resolution and deprotection to give the pure enantiomer (S)-4j. In our work, we got 4j in 20% yield in one-pot procedure from p-methylbenzenesulfonamide. Preparative separation on chiral HPLC afforded two enantiomers. The chirality was determined by comparing the observed optical rotation results with literature (see ESI†).
Sample of SIA 6c and analogues were reported few month ago by Arvidsson through Chan–Evans–Lam C–N cross coupling of aryl boronic acid and sulfonimidamides – key intermediates that were made from tosyl chloride in 6 steps.17 In our work, compound 4e, the key intermediate in Arvidsson's paper was obtained in 87% yield from 1, and 6c was obtained in 25% yield in one-pot procedure from 3.
In conclusion, we have disclosed a multi-step, one-pot procedure to synthesise sulfonimidamides from the corresponding and readily available sulfonamides. The transformation can be performed under mild conditions. 1H NMR was successfully applied in the tautomerism elucidation. Through the replacement of SO in sulfonamides with S
NR, this remarkable functional group transformation affords a new modification opportunity for sulfonamides, an important functional group in drug discovery and development.
Footnote |
† Electronic supplementary information (ESI) available: Experimental procedures and characterization data for compounds 1, 2, 4a–k, 5a–f, and 6a–i. See DOI: 10.1039/c4ra14056g |
This journal is © The Royal Society of Chemistry 2015 |